USP CAR-T Therapy Cuts Liver Fibrosis in Mice | AcademicJobs
USP researchers pioneer in vivo CAR-T therapy using lipid nanoparticles to combat hepatic fibrosis in MASH mouse models, restoring liver function.
in-vivo-car-tresearch-publication-newsbrazilian-research

